Summary This study investigated the hypothesis that inflammatory, regulatory and antioxidant systems control the redox balance in interstitial lung diseases. Spontaneous mRNA expression of inflammatory cytokines and redox-active enzymes was examined in bronchoalveolar lavage (BAL) cells from patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis (SARC) using RT-PCR analysis. Pulmonary oxidative stress was characterized by carbonyl-levels in the soluble BAL-fluid protein.
Introduction
Interstitial lung diseases such as idiopathic pulmonary fibrosis (IPF) [1] [2] [3] [4] and SARC 3, 5 have been linked to an excessive formation of reactive oxygen species (ROS) arising from the imbalance between ROSgenerating and -scavenging systems. These disorders are characterized by the accumulation of leukocytes within the lung, followed by progressive pulmonary inflammation, and subsequent destruction of alveolar-capillary units. While IPF is characterized by an increased number of polymorphonuclear neutrophils (PMN) in the epithelial lining fluid, 6 SARC is accompanied by the occurrence of lymphocytes, 7 thus indicating different pathophysiological mechanisms. The pulmonary redox imbalance in interstitial lung diseases is reflected in (a) an increased oxidative status of bronchoalveolar lavage (BAL)-fluid proteins defined by occurrence of methionine sulfoxide 1 and carbonyl groups 3 in these proteins, (b) a formation of nitrotyrosine and nitric oxide synthase (iNOS) in the lungs of IPF patients using immunohistochemistry, 4 and (c) an activation of NFkB in mononuclear cells isolated from the blood of SARC patients. 5 So far, little is known concerning the influence of redox-active enzymes and inflammatory cytokines on the redox balance in interstitial lung disease. One of the relevant enzymes that contribute to ROS formation is the inducible iNOS. Saleh et al. 4 recently reported that the radical nitric oxide (NO), produced by iNOS, is expressed in macrophages and PMN from patients with early to intermediate stages of IPF. Mn dependent superoxide dismutase (Mn-SOD), glutathione peroxidase (GPx), and g-glutamyl-cysteine synthetase (g-GCS) play a central role in defence of ROS. SOD catalyses the dismutation from superoxide anion radical (O 2 À ) to hydrogen peroxide (H 2 O 2 ), which is further metabolised by GPx. The latter reaction requires reduced glutathione (GSH). De novo synthesis of GSH is dependent on g-GCS, which is the ratelimiting enzyme of this pathway. 8 Among the cytokines, tumour necrosis factor-a (TNF-a) and interleukin (IL-1b) are potent early acting pro-inflammatory cytokines that trigger recruitment of inflammatory cells by inducing the expression of adhesion molecules and chemokines. 9 IL-1b increases proliferation of fibroblasts and may induce the expression of Mn-SOD. 10 IL-8 is a potent chemoattractant for PMN, 11 which represent a major source for ROS. IL-6 induces T-cell proliferation and may be, therefore, particularly relevant to sarcoidosis. On the other hand, IL-6 inhibits the production of IL-1b and TNF-a in mononuclear cells, 12 and is also known as an anti-inflammatory mediator. 13 IL-10 plays a crucial role in down-regulating and terminating inflammation.
14 Interferon-g (INF-g) functionally defines the T helper cell (Th1) response. 15 It inhibits IL-1b and TNF-a induced production of IL-8 in vitro and may thus control PMN recruitment. 16 IL-4 counteracts INF-g and is indicative for the Th2 response. 15 The present study was designed to investigate which of these enzymes and cytokines plays a major role in the modulation of the redox balance in IPF and SARC. We found a strongly enhanced message for IL-8, a normal IL-10/IL-8 ratio, a decreased message for Mn-SOD associated with a marked redox imbalance in IPF. A high level of IL-10 message, a high IL-10/IL-8 ratio, and a strong expression of IFN-g governed the inflammatory response in SARC.
Materials and methods

Study population
Patients with idiopathic pulmonary fibrosis In this group nine patients (4 women and 5 men; mean age 59 years, range 37-74 years; 7 nonsmoker/2 smoker) were studied. The two smoking patients had more than 24 pack years, respectively. The diagnosis of IPF was based on medical history, clinical and physical examinations, chest radiograph, HR-CT, pulmonary function test, bronchoscopy, BAL, and biopsy evidence. Four out of the nine patients had histological confirmation of usual interstitial pneumonia, in all other patients fibrosis was clinically most likely. Two patients received a steroid therapy with 40 mg prednisone at the time of BAL, respectively.
Patients with sarcoidosis
This group consisted of nine patients (5 women and 4 men; mean age 39 years, range 24-55 years; 7 non-smoker/2 smoker). One of the smoking patients had more than 24 pack years, and the other one had 10 pack years. The diagnosis was based on medical history, clinical and physical examinations, chest radiograph, pulmonary function test, bronchoscopy, BAL, and biopsy evidence. By chest X-ray findings three patients were stage I and six were stage II. No steroids were taken at the time of BAL.
Control group
As control subjects, five healthy non-smoking volunteers (4 women, 1 man; mean age 30 years, range 22-41 years), were studied. All volunteers were free of respiratory symptoms and had normal pulmonary function tests.
BAL
BAL was performed after informed consent was obtained from each subject. Using a flexible bronchoscope 3 Â 50 ml of sterile warmed saline was infused into the right middle lope of the lungs and then was immediately collected by suction. The BAL fluids recovered were centrifuged at 500 Â g for 10 min to separate BAL cells from the supernatant. The concentrations of total protein and oxidized protein were determined in the supernatant. The cellular fraction was resuspended in phosphate buffered saline solution and a cell differential was performed on cytospin preparations. Remaining BAL cells (o5 Â 10 6 ) were again centrifuged at 500 Â g for 10 min and lysed with 1 ml 4 M guanidine thiocyanate, 25 mM sodium acetate, 0.5% sodium laurylsarcosine, and 0.12 M 2-mercaptoethanol, pH of 6.0. The lysates were then sheared with four passes through a 22-gauge syringe.
RT-PCR
Total cellular RNA was pelleted from BAL cell lysates by ultracentrifugation through 5.7 M caesium chloride and 0.1 M EDTA. 17 Complementary DNA (cDNA) was generated from total RNA (0.25 mg/ 15 ml) with a RT from the First-Strand cDNA Kit and the pD (N6) primer (Pharmacia, Germany). The resultant cDNA was amplified by PCR using 0.01 ml of the RT reaction for GPx and Mn-SOD, 0.1 ml for GAPDH, IL-8, IL-1b, and g-GCS, 0.5 ml for TNF-a and INF-g, 2 ml for IL-6 and IL-10, and 5 ml for iNOS and IL-4. The respective amounts of the RT reaction were added to Ready To Go PCR beads (Pharmacia, Germany) together with the protein-specific 5 0 and 3 0 primers. Thirty-five cycles were performed with a Hybaid Thermal Cycler (Germany) with settings of 30 s at 951C, 1 min at the respective annealing temperature, and 45 s at 721C. Annealing temperatures were 551C for GAPDH, IL-8, g-GCS, TNF-a, INFg, IL-4, GPx, and Mn-SOD, 581C for IL-1b and IL-6, 591C for IL-10, and 601C for iNOS.
The following primers were utilised: GAPDH 
Quantification of mRNA
We assumed that the mRNA sequences are proportionally represented in the first-strand cDNAs, so that the relative amount of a cDNA sequence represent the relative amount of the corresponding mRNA sequence in the total RNAs. Because we made no adjustment for RT efficiencies, these estimates reflect relative rather than absolute steady-state mRNA levels. The amplification products were first separated on a 1.5% agarose gel containing ethidium bromide and then analysed by a video-densitometer (CCD camera, and 1D Scan software, MWG, Germany). For each protein, the integrated densities were normalized to the ml of RT reaction used in the PCR and then normalized to the constitutively expressed enzyme GAPDH (all enzymes and cytokines) to correct for variation in the amount of amplifiable cDNA in each sample. Predominantly macrophagederived cytokines (IL-1b, TNF-a, IL-8, IL-6, IL-10) were further normalized to the relative number of AM. The ratio obtained was considered to be the relative protein mRNA abundance.
Determination of protein-bound carbonyl groups
BAL supernatants were kept frozen at À251C until analysed. Protein-bound carbonyl groups in frozen samples are stable for at least 2 years (unpublished results). Carbonyl groups were determined as described. 18 Briefly, aliquots of BAL supernatant were dialysed against H 2 O and evaporated to dryness. Carbonyl groups were reduced to alcoholic groups by addition of tritiated borohydride (Pharmacia/Amersham, Germany). To remove tritium labels different from those in amino acids, the tritiated proteins were hydrolysed and the amino acids were separated from carbohydrates by chromatography on Dowex 50 (Biorad, Germany). 18 
Protein determination from the acid hydrolysates
We estimated the protein concentration from the acid hydrolysates by determining the amount of amino acids using o -phthalaldehyde as described. 18 
ARTICLE IN PRESS
The carbonyl content of proteins (oxidized proteins) was expressed as nmol carbonyl/mg BAL fluid protein.
Statistics
Statistical analysis was performed using Statgraphics plus 4.0. Results were expressed as the arithmetic mean7SEM. Significant differences between groups were identified using the non-parametric Mann-Whitney test. Correlation coefficients were determined by the Spearman rank test. Probability values of o0.05 were considered as statistically significant.
Results
None of the smoking patients or the patients that were on prednisone treatment showed a pronounced tendency to differ from the non-smoking patients in the parameters that were measured. Therefore for comparison of groups and statistical evaluation data from all patients were included.
BAL cell counts
Compared to the control group total BAL cell numbers obtained from both IPF and SARC patients were elevated 3.5-fold and 5.3-fold, respectively (Table 1) . Increases in total cell numbers in IPF patients were largely due to an influx of alveolar macrophages, PMN, and lymphocytes. In SARC patients, the increases could be ascribed to an influx of alveolar macrophages and lymphocytes.
BAL fluid protein and their oxidative status
The total protein content of BAL fluid of the control group was 69 mg/ml (Table 1) . This parameter increased 4-fold in the SARC group, but was normal in the IPF-group. The oxidative status of the BAL fluid protein, defined as nmol carbonyl groups/mg protein, increased 2.4-fold in IPF, and remained unchanged in the SARC group.
Analysis of enzyme and cytokine mRNA in BAL cells
Semi-quantitative RT-PCR (Fig. 1) analysis revealed that BAL cells from both IPF and SARC patients expressed lower amounts of specific mRNA for the antioxidant enzymes Mn-SOD (IPF P ¼ 0:033 and SARC P ¼ 0:083) and GPx (IPF P ¼ 0:062 and SARC P ¼ 0:003) than control cells (Fig. 2a) . By contrast, mRNA transcripts of the enzymes iNOS and g-GCS were neither altered in IPF nor in SARC. In IPF, mRNA expression for IL-8 and IL-10 markedly increased (P ¼ 0:004 and 0.003, respectively) and decreased for TNF-a (P ¼ 0:02) compared with controls (Figs. 2b and c) . In contrast, BAL cells from SARC patients showed normal IL-8 and TNF-a mRNA levels (P ¼ 0:14 and 0.5, respectively), while the levels of IL-10 mRNA were elevated (P ¼ 0:003) to a higher extent as in IPF. Figure 1 Patterns of enzyme and cytokine mRNA expression in each subject. Using RT-PCR, total RNA was analyzed for mRNA levels of Mn-SOD, GPx, iNOS, g-GCS, IL-1b, TNF-a, IL-8, IL-6, IL-10, IL-4, and INF-g in BAL cells from control subjects, IPF and SARC patients. Representative ethidium-stained amplification products of all proteins analyzed by agarose gel electrophoresis are shown. The numbers represent the individual subject number. The patients with the numbers 9, 24, 31 and 37 were smokers, and the patients with the numbers 7 and 8 received prednisone before BAL. The IL-10/IL-8 mRNA ratio was 0.0470.03 (mean7SEM) in controls, 0.0770.02 (P ¼ 0:124) in IPF patients, and 0.8670.25 (P ¼ 0:003) in SARC patients, suggesting a prominent role of IL-10 in SARC. INF-g mRNA levels increased 5-fold (P ¼ 0:003) in SARC, but were normal in IPF (Fig.  2c) . Expression of IL-4 mRNA increased in both patient groups (P ¼ 0:004 in IPF, and P ¼ 0:007 in SARC) compared to the control group (Fig. 2c) . No significant differences were observed in the mRNA expression of IL-1b and IL-6 both in IPF and in SARC (Figs. 2b and c) .
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Relationships between oxidized proteins, enzymes and cytokines
Spearman correlation analysis (Table 2a/ 
Discussion
Recent studies have postulated a major role of oxidative stress in the pathogenesis of interstitial lung diseases. [1] [2] [3] [4] [5] The present work was aimed to enlighten the relationship between redox-balance and inflammatory mechanisms in IPF and SARC.
Among the BAL cells, AM exhibit a pivotal role in recruitment and activation of inflammatory cells by releasing different mediators. Major agonists are IL-1b, TNF-a, and IL-8 as pro-inflammatory mediators, the pleiotropic IL-6 which triggers acute phase reactions, and IL-10 as an anti-inflammatory counterpart. Particularly IL-1b and TNF-a influence the expression of various pro-inflammatory chemokines. 9 In this context, cytokines may have a substantial impact on the redox imbalance, which is defined by the net result of radical generating and consuming enzymes. The redox balance was identified in the present study by increased concentrations of protein carbonyls in the epithelial lining fluid.
Cytokine mRNA production in BAL cells was examined as an indication of ongoing cytokine synthesis within the lungs of IPF and SARC patients using RT-PCR analysis. Our data indicate that there is a distinct increase in expression of IL-8 mRNA in IPF coinciding with increased numbers of PMN. By contrast, IL-8 expression in SARC stayed at baseline levels which was consistent with normal numbers of PMN.
Interestingly, increased levels of IL-10 transcripts were observed in IPF and to a higher extent in SARC. Enhanced IL-10 mRNA expression was also described by other authors for IPF 19 and SARC. 20 This cytokine efficiently antagonizes pro-inflammatory responses of alveolar macrophages and other pulmonary cells, e.g. by down-regulating IL-8 expression 21 or inhibition of the respiratory burst activity. 22 The IL-10/IL-8 ratio for specific mRNA expression may provide helpful information on the anti-inflammatory efficiency of IL-10. In IPF, the IL-10/IL-8 ratio was low (0.07) and comparable to the control value (0.04) suggesting the absence of a substantial anti-inflammatory response by IL-10. In SARC, however, the high IL-10/IL-8 ratio of 0.86 implies a strong suppression of IL-8 message, which might abolish the influx of PMN and consequently of PMN-mediated oxidative stress.
Furthermore, the strongly increased expression of IFN-g mRNA in SARC may have regulatory consequences on the inflammatory outcome. Similar changes in IFN-g mRNA production in BAL cells from SARC patients have been described. 20, 23 Robson et al. 16 reported that IFN-g inhibits IL-1b-and TNF-a-induced production of IL-8 in human peritoneal mesothelial cells and thus controls PMN migration across the mesothelium in vitro and in vivo. We propose a similar mechanism for control of PMN migration across the alveolarcapillary barrier in SARC, which supports the antiinflammatory function of IL-10, e.g. in downregulating the expression of IL-8. The positive correlation between IL-10 and Mn-SOD mRNA qlevels in SARC further contributes to the coordination of anti-inflammatory and anti-oxidant mechanisms.
We found no significant changes in the transcript levels for IL-1b, TNF-a and IL-6 in BAL-cells of individuals with both diseases. Our data suggest that the BAL cells were not an important source for these cytokines at the time at which they were sampled in the stage of the diseases. Since we have found at the same time distinctly increased levels of IL-10, more pronounced in SARC than in IPF, the expression of IL-1b, TNF-a, and IL-6 may have been suppressed by IL-10. In contrast to our finding, several studies have reported increased mRNA expression of these three cytokines in IPF 24 and in SARC 20, 24, 25 while others confirm our results. 19, 26 Ziegenhagen et al. 24 showed that in progressing but not in stable IPF and SARC the mRNA levels of TNF-a were increased, and in active SARC increased mRNA levels of TNF-a and IL-6 were found. 20, 25 Thus, apart from technical differences in methodology and detection of mRNA, most likely differences in the patient populations may explain the apparent discrepancies. 27 There is evidence for increased levels of free iron in the blood of IPF patients. 29 Assuming that iron is also increased in their alveolar space the proposed mechanism is very likely. Though the expression of GPx was not significantly altered in IPF, its inverse correlation with protein carbonyls points at a role of this antioxidant enzyme for H 2 O 2 detoxification. In SARC, the absence of an oxidative stress response in terms of carbonyl formation might be explained by normal Mn-SOD expression thus providing a lower O 2 À steady-state concentration than in IPF. As a consequence, the potential for reduction of free Fe 3 þ to Fe 2 þ by O 2 À might not be sufficient to support metal-catalyzed protein oxidation via the Fenton-mechanism even at the significantly lowered expression of GPx. Comparison of the specific carbonyl content in plasma and BAL-fluid in SARCpatients revealed comparable carbonyl levels (data not shown). This observation also suggests the absence of significant oxidative stress in SARC. However, the marked influx of serum protein into the alveolar space might obscure marginally altered redox-processes in the alveolar space.
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The absence of a substantial induction of iNOS implies that NO does not contribute markedly to oxidative stress in IPF. This result is in contrast to the findings by Saleh et al. 4 who reported expression of iNOS in macrophages and PMN from patients with early to intermediate stages of IPF. The discrepancy between these findings may originate from different disease stages of the patient groups and/or from different analytical procedures used, namely RT-PCR in BAL cell extracts versus immunohistochemistry in lung sections. 4 GSH represents an essential antioxidant in the lungs. 8 Previous studies indicated reduced levels of GSH in the epithelial lining fluid of IPF patients, 30 which has been suggested as a relevant feature in pathophysiological mechanism of IPF. In SARC GSH levels were normal. 31 Analysis of the specific mRNA for the heavy subunit of g-GCS as key enzyme in GSH biosynthesis indicated no altered expression of this enzyme in IPF or SARC.
General interpretation
In contrast to IPF, distinct anti-inflammatory mechanisms appear to be activated in SARC, as indicated by the high expression of IL-10 and INF-g transcripts. While high levels of IL-8 mRNA are expressed in IPF, this cytokine does not play a significant role in SARC. The anti-inflammatory IL-10 and presumably INF-g seem to prevent an increased IL-8 expression in SARC thus lowering the risk of oxidant injury by PMN and maintaining the redox balance. The level of oxidized BAL-fluid proteins is markedly increased in IPF compared to SARC patients, whereas the expression profiles of the antioxidant enzymes Mn-SOD and GPx do not show pronounced differences.
Taken together, the redox balance in IPF is strongly shifted in favour of oxidants, and we postulate the explicit involvement of an IL-8 dependent mechanism.
